selegiline has been researched along with Spinal Cord Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gourie-Devi, M; Harsha, HN; Nalini, A; Raju, TR; Rammohan, P; Shahani, N; Shobha, K | 1 |
1 other study(ies) available for selegiline and Spinal Cord Diseases
Article | Year |
---|---|
(-)-Deprenyl alleviates the degenerative changes induced in the neonatal rat spinal cord by CSF from amyotrophic lateral sclerosis patients.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Case-Control Studies; Cell Count; Dose-Response Relationship, Drug; Glial Fibrillary Acidic Protein; Humans; Immunohistochemistry; L-Lactate Dehydrogenase; Neurofilament Proteins; Neuroprotective Agents; Phosphorylation; Rats; Rats, Wistar; Selegiline; Spinal Cord; Spinal Cord Diseases; Time Factors | 2004 |